Rozerem and Tecfidera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rozerem (ramelteon) and Tecfidera (dimethyl fumarate). Common drug interactions include fatigue among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Rozerem and Tecfidera. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Rozerem?

Rozerem has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 7,539 Rozerem users. Check the latest studies of Rozerem.

What is Tecfidera?

Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

27 people who take Rozerem and Tecfidera together, and have interactions are studied.

Rozerem and Tecfidera drug interactions.

What are the common drug interactions of Rozerem and Tecfidera, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Vomiting
  3. Actinic keratosis (skin disease due to sun exposure)
  4. Asthenia (weakness)
  5. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  6. Bowen's disease (early stage of skin cancer)
  7. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  8. Drug ineffective
  9. Lymphocyte count decreased
  10. Maternal exposure during pregnancy (use of substance during pregnancy)

male:

  1. Fall
  2. Flushing (the warm, red condition of human skin)
  3. Depressed level of consciousness
  4. Depression
  5. Device failure
  6. Diarrhoea
  7. Fatigue (feeling of tiredness)
  8. Foot fracture
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Pain

What are the common drug interactions of Rozerem and Tecfidera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Maternal exposure during pregnancy (use of substance during pregnancy)
  2. Visual field defect

30-39:

  1. Fall
  2. Dyslipidaemia (abnormal amount of lipids)
  3. Spinal compression fracture (fracture due to spinal compression on bone)
  4. Abnormal behaviour
  5. Anxiety
  6. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  7. Depression
  8. Device failure
  9. Diarrhoea
  10. Fatigue (feeling of tiredness)

40-49:

  1. Knee arthroplasty
  2. Thrombosis (formation of a blood clot inside a blood vessel)

50-59:

  1. Fatigue (feeling of tiredness)
  2. Actinic keratosis (skin disease due to sun exposure)
  3. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  4. Bowen's disease (early stage of skin cancer)
  5. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  6. Balance disorder
  7. Burning sensation
  8. Decreased interest
  9. Depression
  10. Gait disturbance

60+:

  1. Bradycardia (abnormally slow heart action)
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Pyelonephritis acute (sudden inflammation of kidney caused by bacteria)
  4. Urinary retention (the inability to completely or partially empty the bladder)
  5. Drug ineffective
  6. Gallbladder disorder
  7. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  8. Decreased appetite
  9. Depressed level of consciousness
  10. Pneumonia

What are the existing conditions these people have? *

  1. Dizziness: 3 people, 11.11%
  2. Depression: 3 people, 11.11%
  3. Constipation: 3 people, 11.11%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 7.41%
  5. Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations): 2 people, 7.41%
  6. Neuropathy Peripheral (surface nerve damage): 2 people, 7.41%
  7. Neuralgia (pain in one or more nerves): 2 people, 7.41%
  8. High Blood Pressure: 2 people, 7.41%
  9. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 7.41%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Rozerem and Tecfidera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rozerem and Tecfidera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rozerem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tecfidera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rozerem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tecfidera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ramelteon and dimethyl fumarate (the active ingredients of Rozerem and Tecfidera, respectively), and Rozerem and Tecfidera (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: